Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Cesium carbonate | HCID 10796 | — |
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | Sodium chlorodifluoroacetate | HCID 2734985 | — |
| Reactant | HCID 86690499 | HCID 86690499 | — |
| Solvent | Water | HCID 962 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 86690498 | HCID 86690498 | — |
Reaction Steps
A mixture of N-cyclobutyl-N-{[2-(4-fluoro-3-hydroxyphenyl)pyridin-4-yl]methyl}-1-methyl-1H-imidazole-4-carboxamide (200 mg), sodium chlorodifluoroacetate (190 mg), cesium carbonate (241 mg), dimethylformamide (1.5 mL) and water (0.15 mL) was stirred while heating at 100° C. for 5 hr. After the reaction mixture was cooled in ice, concentrated hydrochloric acid (0.2 mL) was added thereto, and the resulting mixture was stirred for 1 hr. After addition of an aqueous solution of 2M sodium hydroxide, the mixture was extracted with ethyl acetate. The organic phase was separated out, and the solvent was distilled off under reduced pressure. The resulting residue was purified by HPLC. The resulting residue was dissolved in acetonitrile, and 4N hydrochloric acid/ethyl acetate was added thereto, followed by concentration to afford the title compound (30 mg).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08729271B2 |
|---|
| Source dataset | uspto-grants-2014_05 |
|---|
| ORD ID | ord-415912be560940b7ae72087d773f6f25 |
|---|
| Source note | uspto-grants-2014_05 |
|---|